Anzeige
Mehr »
Mittwoch, 20.05.2026 - Börsentäglich über 12.000 News
1.700% Preisexplosion: Wird dieser US-Wolfram-Nanocap jetzt neu bewertet?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0M4YV | ISIN: CNE100000411 | Ticker-Symbol: XIN
Frankfurt
19.05.26 | 08:05
0,655 Euro
0,00 % 0,000
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
SHANDONG XINHUA PHARMACEUTICAL CO LTD Chart 1 Jahr
5-Tage-Chart
SHANDONG XINHUA PHARMACEUTICAL CO LTD 5-Tage-Chart
RealtimeGeldBriefZeit
0,6550,72519.05.

Aktuelle News zur SHANDONG XINHUA PHARMACEUTICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
SHANDONG XINHUA PHARMACEUTICAL Aktie jetzt für 0€ handeln
MoSHANDONG XINHUA Phenobarbital Tablets Pass Generic Drug Consistency Evaluation3
MoSHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT ON PHENOBARBITAL TABLETS HAVING PASSED THE GENERICS CONSISTENCY EVALUATION-
11.05.SHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT ON AMBROXOL HYDROCHLORIDE AND CLENBUTEROL HYDROCHLORIDE ORAL SOLUTION HAVING OBTAINED ...2
08.05.SHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT ON BENSERAZIDE HYDROCHLORIDE HAVING OBTAINED THE NOTIFICATION OF APPROVAL OF MARKETING ...2
28.04.SHANDONG XINHUA 1Q26 Net Profit Down 25.2% YoY to RMB83.9M1
28.04.Shandong Xinhua Pharmaceutical Co. Ltd Q1 Income Falls-
28.04.SHANDONG XINHUA (00719): REMINDER LETTER AND REPLY FORM TO NON-REGISTERED SHAREHOLDERS - REMINDER LETTER REGARDING THE ARRANGEMENT OF ELECTRONIC DISSEMINATION ...-
28.04.SHANDONG XINHUA (00719): REMINDER LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - REMINDER LETTER REGARDING THE ARRANGEMENT OF ELECTRONIC DISSEMINATION ...-
28.04.SHANDONG XINHUA (00719): 2025 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT-
28.04.SHANDONG XINHUA (00719): UNAUDITED FIRST QUARTER RESULTS OF 2026-
28.04.SHANDONG XINHUA (00719): 2025 ANNUAL REPORT-
24.04.SHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT IN RELATION TO OBTAINING OF THE NOTIFICATION OF APPROVAL OF SUPPLEMENTARY DRUG ...1
15.04.SHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT ON BUMETANIDE INJECTION HAVING OBTAINED DRUG REGISTRATION CERTIFICATE1
15.04.SHANDONG XINHUA (00719): ANNOUNCEMENT NOTICE OF BOARD MEETING1
07.04.SHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT ON SODIUM POTASSIUM MAGNESIUM AND CALCIUM CONCENTRATED SOLUTION FOR INJECTION HAVING ...-
01.04.SHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT IN RELATION TO OBTAINING OF THE NOTIFICATION OF APPROVAL OF SUPPLEMENTARY DRUG ...-
31.03.SHANDONG XINHUA (00719): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS-
31.03.SHANDONG XINHUA (00719): RESIGNATION OF NON-EXECUTIVE DIRECTOR2
27.03.Shandong Xinhua Pharmaceutical Co. Ltd Profit Retreats In Full Year-
27.03.SHANDONG XINHUA (00719): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 20252
Weiter >>
39 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1